Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Receivables (2024 - 2025)

Historic Receivables for Korro Bio (KRRO) over the last 2 years, with Q3 2025 value amounting to $800000.0.

  • Korro Bio's Receivables fell 9200.0% to $800000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $800000.0, marking a year-over-year decrease of 9200.0%. This contributed to the annual value of $1.7 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Korro Bio's Receivables stood at $800000.0, which was down 9200.0% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Receivables ranged from a high of $10.0 million in Q3 2024 and a low of $800000.0 during Q3 2025